Bank of New York Mellon’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.34B Sell
3,695,586
-97,857
-3% -$33.5M 0.22% 76
2026
Q1
$1.33B Sell
3,793,443
-113,573
-3% -$40.5M 0.25% 75
2025
Q4
$1.28B Sell
3,907,016
-72,170
-2% -$22.9M 0.23% 81
2025
Q3
$1.12B Sell
3,979,186
-24,318
-0.6% -$7.05M 0.2% 94
2025
Q2
$1.12B Sell
4,003,504
-446,593
-10% -$127M 0.21% 91
2025
Q1
$1.39B Sell
4,450,097
-131,068
-3% -$38.7M 0.27% 68
2024
Q4
$1.19B Sell
4,581,165
-599,610
-12% -$178M 0.22% 81
2024
Q3
$1.67B Sell
5,180,775
-182,836
-3% -$59.8M 0.31% 55
2024
Q2
$1.68B Buy
5,363,611
+4,608
+0.1% +$1.35M 0.32% 54
2024
Q1
$1.52B Sell
5,359,003
-133,350
-2% -$39M 0.29% 69
2023
Q4
$1.58B Buy
5,492,353
+55,171
+1% +$15M 0.32% 59
2023
Q3
$1.46B Buy
5,437,182
+61,528
+1% +$15.4M 0.32% 56
2023
Q2
$1.19B Sell
5,375,654
-39,086
-0.7% -$9.07M 0.25% 78
2023
Q1
$1.31B Sell
5,414,740
-100,023
-2% -$24.6M 0.29% 70
2022
Q4
$1.45B Sell
5,514,763
-454,780
-8% -$122M 0.33% 57
2022
Q3
$1.35B Sell
5,969,543
-11,375
-0.2% -$2.76M 0.33% 59
2022
Q2
$1.46B Sell
5,980,918
-44,247
-0.7% -$10.8M 0.33% 59
2022
Q1
$1.46B Sell
6,025,165
-280,575
-4% -$64.5M 0.28% 76
2021
Q4
$1.42B Buy
6,305,740
+335,068
+6% +$70.7M 0.26% 81
2021
Q3
$1.27B Sell
5,970,672
-11,300
-0.2% -$2.6M 0.25% 78
2021
Q2
$1.46B Sell
5,981,972
-413,740
-6% -$102M 0.28% 71
2021
Q1
$1.59B Sell
6,395,712
-120,477
-2% -$28.7M 0.33% 65
2020
Q4
$1.5B Sell
6,516,189
-345,684
-5% -$79.7M 0.33% 68
2020
Q3
$1.74B Buy
6,861,873
+178,623
+3% +$44.3M 0.43% 43
2020
Q2
$1.58B Buy
6,683,250
+171,906
+3% +$39.2M 0.42% 47
2020
Q1
$1.32B Sell
6,511,344
-294,594
-4% -$64.3M 0.44% 48
2019
Q4
$1.64B Buy
6,805,938
+8,049
+0.1% +$1.77M 0.42% 44
2019
Q3
$1.32B Buy
6,797,889
+106,998
+2% +$20.5M 0.36% 57
2019
Q2
$1.23B Sell
6,690,891
-190,065
-3% -$34M 0.34% 64
2019
Q1
$1.31B Buy
6,880,956
+40,838
+0.6% +$7.8M 0.37% 55
2018
Q4
$1.33B Sell
6,840,118
-361,153
-5% -$70.5M 0.42% 45
2018
Q3
$1.49B Sell
7,201,271
-71,116
-1% -$14M 0.38% 50
2018
Q2
$1.34B Sell
7,272,387
-217,483
-3% -$38.5M 0.37% 55
2018
Q1
$1.28B Sell
7,489,870
-517,735
-6% -$95M 0.35% 56
2017
Q4
$1.39B Sell
8,007,605
-158,397
-2% -$28M 0.37% 54
2017
Q3
$1.52B Buy
8,166,002
+140,117
+2% +$24.8M 0.42% 43
2017
Q2
$1.38B Sell
8,025,885
-529,471
-6% -$86.1M 0.39% 50
2017
Q1
$1.4B Buy
8,555,356
+195,200
+2% +$32.4M 0.39% 46
2016
Q4
$1.22B Buy
8,360,156
+307,731
+4% +$46.3M 0.35% 51
2016
Q3
$1.34B Sell
8,052,425
-143,157
-2% -$24.2M 0.4% 49
2016
Q2
$1.25B Sell
8,195,582
-568,008
-6% -$88.3M 0.38% 56
2016
Q1
$1.31B Sell
8,763,590
-368,264
-4% -$54.7M 0.4% 51
2015
Q4
$1.48B Sell
9,131,854
-33,313
-0.4% -$5.24M 0.45% 43
2015
Q3
$1.27B Sell
9,165,167
-313,032
-3% -$49.3M 0.39% 54
2015
Q2
$1.46B Sell
9,478,199
-401,107
-4% -$64.3M 0.4% 51
2015
Q1
$1.58B Sell
9,879,306
-556,765
-5% -$87.7M 0.41% 47
2014
Q4
$1.66B Sell
10,436,071
-87,207
-0.8% -$13.6M 0.43% 44
2014
Q3
$1.48B Buy
10,523,278
+96,711
+0.9% +$12.6M 0.4% 48
2014
Q2
$1.23B Sell
10,426,567
-964,351
-8% -$112M 0.33% 57
2014
Q1
$1.4B Sell
11,390,918
-249,538
-2% -$30.3M 0.38% 48
2013
Q4
$1.33B Buy
11,640,456
+216,262
+2% +$24.6M 0.37% 49
2013
Q3
$1.28B Buy
11,424,194
+1,471,385
+15% +$160M 0.38% 49
2013
Q2
$982M Buy
+9,952,809
New +$1.03B 0.31% 62

Other funds holding AMGN

Bank of New York Mellon's AMGN Position: Q2 2026 in Review

Bank of New York Mellon reduced its Amgen (AMGN) stake by 2.6% in Q2 2026, selling an estimated $33.5M and leaving 3,695,586 shares worth $1.34B. The position accounts for 0.22% of the portfolio, ranked #76.

Bank of New York Mellon first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.74B in Q3 2020. 2,083 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Bank of New York Mellon held 3,695,586 shares of Amgen worth $1.34B as of Q2 2026.
  • Bank of New York Mellon sold 97,857 Amgen shares in Q2 2026, an estimated $33.5M.
  • Amgen made up 0.22% of Bank of New York Mellon's portfolio in Q2 2026, its #76 holding.
  • Bank of New York Mellon first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Bank of New York Mellon's Amgen position peaked at $1.74B in Q3 2020.
  • 2,083 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.